| Literature DB >> 32838287 |
Haisheng Wu1, Qingwen Zhang1, Hailian Wu1, Fuzhang Tian1, Baizhong Cui1, Zhizhen Qi1, Xiaoqing Xu1, Xuefei Zhang1, Hu Wang2.
Abstract
Plague, caused by Yersinia pestis, is a natural focus infectious disease. In China, plague is classified as category A, with the highest risk and hazard among the infectious diseases. Qinghai used to be considered as one of the most serious areas of plague in China. In recent years, thank to the measures in eight aspects summarized as the "Qinghai model" which were adopted to prevent and control the human plague in Qinghai, Qinghai has not experienced any plague case reported for eight years. In early 2020, coronavirus disease 2019 (COVID-19) outbroke in China. The Qinghai model on plague was employed to deal with the COVID-19 emergency in Qinghai Province. The Qinghai Center for Disease Control and Prevention (Qinghai CDC) and hospitals, along with the departments of public security, animal husbandry and other departments, quickly tracked and treated the patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and started surveillance programs on close contacts timely. At present, the cure rate of patients has reached 100%, and close contacts have been effectively quarantined and tested to avoid the spread of COVID-19. The findings from the study suggest that the prevention and control measures undertaken in Qinghai Province might be effective in dealing with the category A infectious diseases such as COVID-19 and other diseases.Entities:
Keywords: COVID-19; Plague; Public health; Qinghai model
Year: 2020 PMID: 32838287 PMCID: PMC7403129 DOI: 10.1016/j.bsheal.2020.08.001
Source DB: PubMed Journal: Biosaf Health ISSN: 2590-0536
First infections in human plague epidemics in Qinghai Province from 1975 to 2019.
| Cause of infection | Number of infections at the start of the epidemic | Percentage |
|---|---|---|
| Eating marmot ( | 46 | 58.22% |
| Eating Tibetan sheep ( | 12 | 15.19% |
| Eating Mongolian gazelle ( | 2 | 2.53% |
| Contact with dog ( | 3 | 3.79% |
| Peeled skin from dead lynx ( | 1 | 1.27% |
| Peeled skin from desert cat ( | 1 | 1.27% |
| Contact with plateau pika ( | 1 | 1.27% |
| Contact with hare ( | 1 | 1.27% |
| Flea bite ( | 7 | 8.86% |
| Peeled skin from fox ( | 1 | 1.27% |
| Unknown | 4 | 5.06% |
Fig. 1Epidemics of human plague in Qinghai province from 1958 to 2019.
Fig. 2Overview of each department's roles in the organizational structure.
Comparison of the characteristics of Plague and COVID-19.
| Aspects | Plague | COVID-19 |
|---|---|---|
| Classification of disease | Category A | Category B but implemented for category A |
| Pathogen | Bacterium; | Virus; SARS-CoV-2 |
| Biohazards classification | Level 3 | Level 3 or Level 4 |
| Infectivity | Highly | Highly |
| Transmission route | Respiratory tract; Contact; Blood (Pneumonic, Septicemic plague); Flea bite (Bubonic plague) | Respiratory tract; Contact; Blood |
| Pathogenicity | Severe | Severe |
| Infection incubation | 1–9 days | 1–14 days |
| Susceptibility | High incidence of susceptible population | High incidence of susceptible population |
| Preclinical susceptibility | Exist and high | Exist and high; Asymptomatic COVID positive people are contagious |
| Mortality | Without timely intervention of antibacterial drugs exceeds 80% | The exact death rate is not known, but it currently stands at about 3%. |
| Test methods | Culture; PCR; Rapid Diagnostic Test (RDT) for F1-antigen; antibody detection by serology | RT-PCR; detecting of SARS-CoV-2 IgM and IgG antibody |
| Clinical symptoms | High fever, chills, weakness, headache, lymphadenopathy (bubonic plague); vomiting, respiratory distress (pneumonic plague) tachycardia; shock; Disseminated Intravascular Coagulation (DIC) | Fever, fatigue and cough are common. A few have nasal congestion, runny nose, sore throat, muscle pain and diarrhea. Acute respiratory distress syndrome and septic shock in severe patients |
| Treatment | Isolation; symptomatic support; antibacterial treatment (Streptomycin preferred or gentamicin, doxycycline) | Isolation; symptomatic support; Lack of effective antiviral drugs |